IP Verse

Celgene Corporation V. Teva Pharmaceuticals, Inc. - 1:23-cv-01008

Explore the details of the Celgene Corporation V. Teva Pharmaceuticals, Inc. case under case number 1:23-cv-01008 involving a cause of action for Patent Infringement. Review key information about the parties involved, the patents in question, and the docket entries.

Case Details

Case Number
1:23-cv-01008
Filing Date
Sep 13, 2023
Cause of Action
Patent Infringement
Status
-
Nature of Suit
Patent - Abbreviated New Drug Application(ANDA)

Parties Involved in the Case

The following parties are involved in this case, with their respective legal representatives for the case.

NameRepresented By
Celgene Corporation -
Bristol-Myers Squibb Company -
Natco Pharma Limited -
Teva Pharmaceuticals, Inc. -

Patents Involved in the Case

This case involves 2 patents, each of which is central to the dispute. These patents may be subject to claims of infringement, challenges to their validity, or other issues concerning their scope and enforcement.

Application NumberPatent Number
-US8846628B2
-US11571436B2

Docket Entries

The Docket Entries section provides a chronological list of all significant filings and court actions in this case.

DateDocket EntryType

Set alerts for critical docket entry

Apr 30, 2024CONSENT JUDGMENT and Order of Dismissal between Plaintiffs and Defendant Teva Pharmaceuticals, Inc. Signed by Judge Jennifer L. Hall on 4/30/2024. (ceg) (Entered: 04/30/2024)PACER Document
May 23, 2024PROPOSED Consent Judgment and Order of Dismissal of Defendant Natco Pharma Ltd., by Bristol-Myers Squibb Company, Celgene Corporation, Celgene International Sarl. (Farnan, Michael) Modified on 5/23/2024 (ceg). (Entered: 05/23/2024)PACER Document
May 29, 2024Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,846,628 B2; US 11,571,436 B2. (Attachments: # 1 Consent Judgment - Natco Pharma Ltd., # 2 Consent Judgment - Teva Pharmaceuticals, Inc.)(ceg) (Entered: 05/29/2024)PACER Document
May 29, 2024CONSENT JUDGMENT and Order of Dismissal between Plaintiffs and Defendant Natco Pharma Ltd. Signed by Judge Jennifer L. Hall on 5/29/2024. (ceg) (Entered: 05/29/2024)PACER Document
Sep 20, 2023Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb)PACER Document
Sep 20, 2023SO ORDERED, re 8 MOTION for Pro Hac Vice Appearance of Attorney Amy K. Wigmore, Heather M. Petruzzi, Andrew J. Danford, Nora Q.E. Passamaneck, David Mlaver, Gerard A. Salvatore, and Li-tsung Alyssa Chen, filed by Celgene Corporation, Celgene International Sarl, Bristol-Myers Squibb Company. Signed by Judge Richard G. Andrews on 9/20/2023. (nms)PACER Document
Sep 20, 2023DEFICIENCY NOTICE issued by the Court to Defendant: Pursuant to Fed. R. Civ. P. 7.1 (b)(1), A party must: (1) file the disclosure statement with its first appearance, pleading, petition, motion, response, or other request addressed to the court. Counsel is requested to supplement the docket with an appropriate Rule 7.1 Disclosure Statement. (nms)PACER Document
Sep 26, 2023SO ORDERED, re 11 STIPULATION to Extend Time (*Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 11/6/2023). Signed by Judge Richard G. Andrews on 9/26/2023. (nms)PACER Document
Sep 27, 2023Pro Hac Vice Attorney Heather M. Petruzzi, Amy K. Wigmore, Gerard A. Salvatore, Nora Q.E. Passamaneck, Andrew J. Danford, and Li-tsung A. Chen for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-01008-RGA, 1:23-cv-01019-RGA(mpb)PACER Document
Sep 27, 2023Pro Hac Vice Attorney David Mlaver for Celgene Corporation added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:23-cv-01008-RGA, 1:23-cv-01019-RGA(mpb)PACER Document
Oct 23, 2023SO ORDERED, re 12 MOTION for Pro Hac Vice Appearance of Attorney George Lombardi, Ivan Poullaos and Elise M. LeCrone, filed by Teva Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 10/23/2023. (nms)PACER Document
Oct 24, 2023Pro Hac Vice Attorney Ivan M. Poullaos,George C. Lombardi, and Elise M. LeCrone for Teva Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mkr)PACER Document
Oct 26, 2023SO ORDERED, re 13 STIPULATION to Extend Time (*Reset Answer Deadlines: Teva Pharmaceuticals, Inc. answer due 11/20/2023). Signed by Judge Richard G. Andrews on 10/26/2023. (nms)PACER Document
Nov 17, 2023SO ORDERED, re 14 MOTION for Pro Hac Vice Appearance of Attorney Kevin Boyle, filed by Teva Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 11/17/2023. (nms)PACER Document
Nov 20, 2023Pro Hac Vice Attorney Kevin J. Boyle for Teva Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk)PACER Document
Jan 16, 2024Case Reassigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. Associated Cases: 1:21-cv-01795-RGA, 1:23-cv-00699-RGA, 1:23-cv-01008-RGA, 1:23-cv-01019-RGA(nms)PACER Document
Jan 22, 2024ORAL ORDER: IT IS HEREBY ORDERED that the Scheduling Conference scheduled for February 5, 2024 is RESCHEDULED February 23, 2024 at 10:00 AM in Courtroom 6D before Judge Jennifer L. Hall. Ordered by Judge Jennifer L. Hall on 1/22/2024. Associated Cases: 1:23-cv-01008-JLH, 1:23-cv-01019-JLH(ceg)PACER Document
Feb 21, 2024ORAL ORDER: The Rule 16(b) Conference scheduled for February 23, 2024 is CANCELLED. Ordered by Judge Jennifer L. Hall on 2/21/2024. Associated Cases: 1:23-cv-01008-JLH, 1:23-cv-01019-JLH(ceg) (Entered: 02/21/2024)PACER Document
Feb 23, 2024***Party Natco Pharma Limited added. ***Attorney James S. Green, Jr., Andrew O. Larsen, Christopher J. Sorenson, and Jason M. Wiener for Natco Pharma Limited added. (ceg)PACER Document
Mar 26, 2024SO ORDERED, re 28 Stipulation and Order for Extension of Time for Plaintiffs and Natco Defendants to serve Initial Disclosures pursuant to the Delaware Default Standard for Discovery to April 8, 2024. Ordered by Judge Jennifer L. Hall on 3/26/2024. (ceg)PACER Document